Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Articles
Perspectives
The Challenge of Balancing Access to and Paying for New, High-Cost Cancer Therapies
Read More
Leukemia
,
Oncology
Refining the Use of CAR T-Cells in Patients with Acute Lymphoblastic Leukemia
Read More
Leukemia
,
Oncology
CAR T-Cell Therapy Produces High Response Rates in Refractory B-Cell Malignancies
Read More
Breast Cancer
,
Oncology
Extending Letrozole Therapy Beyond 5 Years in Early Breast Cancer Reduces Recurrence
Read More
Multiple Myeloma
,
Oncology
Three-Drug Regimen with Daratumumab a New Standard of Care for Relapsed or Refractory Multiple Myeloma
Read More
Atezolizumab Could Be Start of “Seismic Shift” in Metastatic Bladder Cancer Therapy
Read More
Multiple Myeloma
,
Oncology
Targeting CD38, Isatuximab Produces Impressive Responses in Relapsed or Refractory Multiple Myeloma
Read More
Gene-Expression Signature Validated as Prognostic Marker in Stage II Colon Cancer
Read More
Melanoma
,
Oncology
Combination Immunotherapy Makes Progress in Advanced Melanoma
Read More
A New Paradigm Matching Targeted Therapy to Molecular Alterations Independent of Tumor Type
Read More
103
104
105
106
107
108
109
Page 106 of 244
Results 1051 - 1060 of 2434